Vedantra Pharmaceuticals, Inc. — Form D

Vedantra Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2012-07-31. The offering totals $5.0M, of which $3.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Daniel BehrDirectorWestborough, MA
Ben BronsteinDirectorWestborough, MA
Alan ShawDirectorCambridge, MA
Alan ShawExecutive OfficerCambridge, MA
Alan ShawPromoterCambridge, MA
Yekaterina ChudnovskyDirectorLOS ANGELES, CA
Christopher HaqqExecutive OfficerBoston, MA
Carol AsheDirectorBoston, MA
Robert ConnellyDirectorBoston, MA
Robert ConnellyExecutive OfficerBoston, MA
Robert RuffoloDirectorBoston, MA
Julian AdamsDirectorBoston, MA
Julian AdamsExecutive OfficerBoston, MA
Annette MatthiesExecutive OfficerBoston, MA
Assaf SegalDirectorBoston, MA
Daniel GeffkenDirectorBoston, MA
Daniel GeffkenExecutive OfficerBoston, MA
Daphne KarydasDirectorBrooklyn, NY
Ofer GonenDirectorYavne, L3
Isaac KohlbergDirectorCambridge, MA
Frank HaluskaDirectorCambridge, MA
Isaac BlechDirectorJupiter, FL
William KosterDirectorWestborough, MA
Satish JindalDirectorCleveland, OH
Steve DeitcherDirectorCambridge, MA

Other filings by this issuer (12)

FiledFormOfferingSold
2022-11-02D/A$50.0M$22.0M
2022-05-27D$50.0M$975K
2021-11-18D/A$15.0M$14.5M
2021-11-12D/A$15.0M$14.5M
2021-10-19D$15.0M$2.0M
2020-07-15D$30.0M$6.1M
2020-03-13D$8.4M$8.4M
2019-10-15D$7.0M$7.0M
2018-09-14D$36.2M$25.8M
2018-08-03D$14.5M$14.5M
2018-06-05D$3.0M$3.0M
2016-05-24D$1.5M$750K

More